Human respiratory syncytial virus infects and induces activation markers in mouse B lymphocytes

Immunology and Cell Biology

Volumn 87, Issue 4, 2009, Pages 344-350

  Ángel Rico, Miguel ^a   Trento, Alfonsina ^b   Ramos, Manuel ^a   Johnstone, Carolina ^a   Del Val, Margarita ^a,c   Melero, José Antonio ^b   López, Daniel ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

B cells; FACS; Respiratory models; Viral immunity

Indexed keywords

CD45 ANTIGEN; CD86 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; BIOLOGICAL MARKER; GLYCOSAMINOGLYCAN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; INFECTION SENSITIVITY; MOUSE; NONHUMAN; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SPLEEN CELL; VIRUS RESISTANCE; ANIMAL; B LYMPHOCYTE; C57BL MOUSE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS INFECTION;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; HYDRANGEA RINGSPOT VIRUS;

ANIMALS; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; GLYCOSAMINOGLYCANS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

EID: 67449089685     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2008.109     Document Type: Article

References (46)

1. Whitton JL, Oldstone MBA. The immune response to viruses. In: Knipe DM and Howley PM (ed.) Fields Virology. Lippincott Williams & Wilkins, 2007, pp 285-320.
2. Collins PL, Chanock RM, Murphy BR. Respiratory syncytial virus. In: Knipe DM and Howley PM (ed.) Fields Virology. Lippincott Williams & Wilkins, 2007, pp 1443-1486.
3. Hall CB. Respiratory syncytial virus and parainfluenza virus. NEnglJMed 2001; 344: 1917-1928.
4. Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J infect Dis 2001; 183:16-22.
5. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ etal. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-186.
6. Wendt CH, Hertz MI. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Semin Respir Infect 1995; 10:224-231.
7. Ison MG, Hayden FG. Viral infections in immunocompromised patients: what's newwith respiratory viruses? Curr Opin Infect Dis 2002; 15: 355-367.
8. Han LL, Alexander JP, Anderson LJ. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis 1999; 179:25-30.
9. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. NEnglJMed 2005; 352: 1749-1759.
10. Becker S, Quay J, Soukup J. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J Immunol 1991; 147: 4307-4312.
11. Midulla F, Huang YT, Gilbert IA, Cirino NM, McFadden Jr ER, Panuska JR. Respiratory syncytial virus infection of human cord and adult blood monocytes and alveolar macrophages. Am Rev Respir Dis 1989; 140:771-777.
12. Panuska JR, Cirino NM, Midulla F, Despot JE, McFadden Jr ER, Huang YT. Productive infection of isolated human alveolar macrophages by respiratory syncytial virus. J Clin Invest 1990; 86: 113-119.
13. Bartz H, Buning-Pfaue F, Turkel O, Schauer U. Respiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cells. Clin Exp Immunol 2002; 129: 438-445.
14. Peebles Jr RS, Graham BS. Pathogenesis of respiratory syncytial virus infection in the murine model. Proc Am Thorac Soc 2005; 2: 110-115.
15. Franke-Ullmann G, Pfortner C, Walter P, Steinmuller C, Lohmann-Matthes ML, Kobzik L et al. Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro. JImmunol 1995; 154: 268-280.
16. Wang H, Peters N, Schwarze J. Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. JImmunol 2006; 177: 6263-6270.
17. Openshaw PJM, Tregoning JS. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microbiol Rev 2005; 18: 541-555.
18. Valarcher JF, Bourhy H, Lavenu A, Bourges-Abella N, Roth M, Andreoletti O et al. Persistent infection of B lymphocytes by bovine respiratory syncytial virus. Virology 2001; 291:55-67.
19. Hallak LK, Spillmann D, Collins PL, Peeples ME. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. JVirol 2000; 74: 10508-10513.
20. Krusat T, Streckert HJ. Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells. Arch Virol 1997; 142: 1247-1254.
21. Martinez I, Melero JA. Binding of human respiratorysyncytial virus to cells: implication of sulfated cell surface proteoglycans. JGenVirol 2000; 81: 2715-2722.
22. Hallak LK, Collins PL, Knudson W, Peeples ME. Iduronic acid-containing glycosami- noglycans on target cells are required for efficient respiratory syncytial virus infection. Virology 2000; 271 : 264-275.
23. Mach B, Steimle V, Martinez-Soria E, Reith W. Regulation of MHC class II genes: lessons from a disease. Annu Rev Immunol 1996; 14: 301-331.
24. Collins M, Ling V, Carreno BM. The B7 family of immune-regulatory ligands. Genome Biol 2005; 6:223.
25. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000; 1:398-401.
26. Gaddum RM, Cook RS, Wyld SG, Lopez JA, Bustos R, Melero JA etal. Mutant forms of the F protein of human respiratory syncytial (RS) virus induce a cytotoxic T lymphocyte response but not a neutralizing antibody response and only transient resistance to RS virus infection. JGen Virol 1996; 77: 1239-1248.
27. Manakil JF, Seymour GJ, Bartold PM. Effect of cytokine and antigen stimulation on peripheral blood lymphocyte syndecan-1 expression. Oral Microbiol Immunol 2007; 22: 272-276.
28. Garofalo R, Mei F, Espejo R, Ye G, Haeberle H, Baron S etal. Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha. JImmunol 1996; 157: 2506-2513.
29. Hornung V, Schlender J, Guenthner-Biller M, Rothenfusser S, Endres S, Conzelmann KK et al. Replication-dependent potent IFN-alpha induction in human plasmacytoid dendritic cells by a single-stranded RNA virus. J Immunol 2004; 173: 5935-5943.
30. Wright SD. CD14 and innate recognition of bacteria. JImmunol 1995; 155:6-8.
31. Miyake K, Yamashita Y, Ogata M, Sudo T, Kimoto M. RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. JImmunol 1995; 154: 3333-3340.
32. De Graaff PM, de Jong EC, van Capel TM, van Dijk ME, Roholl PJ, Boes J et al. Respiratorysyncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4T cells. JImmunol 2005; 175: 5904-5911.
33. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997; 388: 782-787.
34. Pierre P, Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 1998; 93: 1135-1145.
35. Hsing LC, Rudensky AY. The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol Rev 2005; 207: 229-241.
36. Bangham CR, McMichael AJ. Specific human cytotoxic T cells recognize B-cell lines persistentlyinfected with respiratorysyncytial virus. ProcNatl AcadSci USA 1986; 83: 9183-9187.
37. Thurau AM, Streckert HJ, Rieger CH, Schauer U. Increased number of T cells committed to IL-5 production after respiratory syncytial virus (RSV) infection of human mononuclear cells in vitro. Clin Exp Immunol 1998; 113: 450-455.
38. Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol 2002; 2: 116-126.
39. Lenschow DJ, Su GH, Zuckerman LA, Nabavi N, Jellis CL, Gray GS etal. Expression and functional significance of an additional ligand for CTLA-4. Proc Natl Acad Sci USA 1993; 90: 11054-11058.
40. Hasler P, Zouali M. Subversion of B lymphocyte signaling by infectious agents. Genes Immun 2003; 4: 95-103.
41. Schlender J, Walliser G, Fricke J, Conzelmann KK. Respiratory syncytial virus fusion protein mediates inhibition of mitogen-induced T-cell proliferation by contact. JVirol 2002; 76: 1163-1170.
42. Streckert HJ, Philippou S, Riedel F. Detection of respiratory syncytial virus (RSV) antigen in the lungs of guinea pigs 6 weeks after experimental infection and despite of the production of neutralizing antibodies. Arch Virol 1996; 141: 401-410.
43. Valosky J, Hishiki H, Zaoutis TE, Coffin SE. Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus. Clin Diagn Lab Immunol 2005; 12:171-179.
44. Jaovisidha P, Peeples ME, Brees AA, Carpenter LR, MoyJN. Respiratory syncytial virus stimulates neutrophil degranulation and chemokine release. J Immunol 1999; 163: 2816-2820.
45. Bartz H, Turkel O, Hoffjan S, Rothoeft T, Gonschorek A, Schauer U. Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon- gamma in naive T cells. Immunology 2003; 109:49-57.
46. Garcla-Barreno B, Palomo C, Perias C, Delgado T, Pterez-Breria P, Melero JA. Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. JVirol 1989; 63:925-932.